Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 59934-59948 |
| Number of pages | 15 |
| Journal | ACS applied materials & interfaces |
| Volume | 16 |
| Issue number | 44 |
| Early online date | 24 Oct 2024 |
| DOIs | |
| Publication status | Published - 6 Nov 2024 |
Funding
This study was supported by Grants PID2021-126014OB-I00 and PID2021-122212OA-I00 funded by the MCIN/AEI/10.13039/501100011033/FEDER,UE, and by the Grant IT1449-22 funded by the Basque Government. S.I. acknowledges a research contract from the University of the Basque Country (DOCREC21/20). A.R.-C. acknowledges a predoctoral contract from the Basque Government. C.D. acknowledges PRACE for awarding access to computational resources in CSCS, the Swiss National Supercomputing Service, in two of their Project Access Calls. This project also made use of computing time on UK Tier 2 JADE and Bede, granted via the UK High-End Computing Consortium for Biomolecular Simulation, HECBioSim ( http://hecbiosim.ac.uk ), supported by EPSRC (grant no. EP/R029407/1). B.W. was supported by U.K. Research and Innovation (UKRI), grant reference number EP/S023437/1. M.Z. acknowledges funding support from the US National Institutes of Health R01-AI143563. E.R. acknowledges funding by the ERC (grant H2020-MSCA-COFUND-2020-101034228-WOLFRAM2). This work was also supported by the Platform Project for Supporting Drug Discovery and Life Science Research [Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)] from AMED (24ama121031j0003) to A.O. and J.M.M.C. Technical assistance by Miguel Garcia-Porras is greatly acknowledged. The authors also wish to thank Pablo Carravilla for helpful discussions on the content of the manuscript and for his assistance in the production of A. For the purpose of open access, B.W. has applied a Creative Commons Attribution (CC-BY) license to any Author Accepted Manuscript version arising.
| Funders | Funder number |
|---|---|
| Eusko Jaurlaritza - Gobierno Vasco | |
| Japan Agency for Medical Research and Development | 24ama121031j0003 |
| Japan Agency for Medical Research and Development | |
| European Research Council | H2020-MSCA-COFUND-2020-101034228-WOLFRAM2 |
| European Research Council | |
| Engineering and Physical Sciences Research Council | EP/R029407/1 |
| Engineering and Physical Sciences Research Council | |
| National Institutes of Health | R01-AI143563 |
| National Institutes of Health | |
| UK Research & Innovation | EP/S023437/1 |
| UK Research & Innovation | |
| University of the Basque Country | DOCREC21/20 |
| University of the Basque Country |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- HIV-1 antibody
- antibody engineering
- antibody-membrane interaction
- lipid nanoenvironment
- membrane deformation
- metadynamics
- molecular dynamics simulations
- site-selective chemical modification
ASJC Scopus subject areas
- General Materials Science
Fingerprint
Dive into the research topics of 'Generation of a Nonbilayer Lipid Nanoenvironment after Epitope Binding Potentiates Neutralizing HIV-1 MPER Antibody'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS